Spare the rods, save the cones in aging and age-related maculopathy.
about
Violet and blue light blocking intraocular lenses: photoprotection versus photoreceptionAMD and the alternative complement pathway: genetics and functional implicationsProtecting the melatonin rhythm through circadian healthy light exposureDifferential stimulation of the retina with subretinally injected exogenous neurotransmitter: A biomimetic alternative to electrical stimulationScotopic microperimetry in the early diagnosis of age-related macular degeneration: preliminary study.Developing rods transplanted into the degenerating retina of Crx-knockout mice exhibit neural activity similar to native photoreceptorsIndividual variations in human cone photoreceptor packing density: variations with refractive error.Night vision symptoms and progression of age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial.Characterization of outer retinal morphology with high-speed, ultrahigh-resolution optical coherence tomography.Nutritional manipulation of primate retinas, V: effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damageAssociations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular healthQuantitative autofluorescence and cell density maps of the human retinal pigment epithelium.Age-related deterioration of rod vision in mice.Electrostatic compensation restores trafficking of the autosomal recessive retinitis pigmentosa E150K opsin mutant to the plasma membrane.A model of spectral filtering to reduce photochemical damage in age-related macular degeneration.Association of dark-adapted visual function with retinal structural changes in patients with Stargardt disease.In vivo imaging of photoreceptor disruption associated with age-related macular degeneration: A pilot study.Age-related macular degeneration: genetics and biology coming together.Delayed Rod-Mediated Dark Adaptation Is a Functional Biomarker for Incident Early Age-Related Macular Degeneration.Age-related macular degeneration: insights into inflammatory genes.Persons with age-related maculopathy risk genotypes and clinically normal eyes have reduced mesopic visionDendrites of rod bipolar cells sprout in normal aging retina.Macular cone abnormalities in retinitis pigmentosa with preserved central vision using adaptive optics scanning laser ophthalmoscopyNoninvasive imaging of the human rod photoreceptor mosaic using a confocal adaptive optics scanning ophthalmoscope.Quantitative analysis of cone photoreceptor distribution and its relationship with axial length, age, and early age-related macular degeneration.Spatial and temporal variation of rod photoreceptor reflectance in the human retina.Lipofuscin redistribution and loss accompanied by cytoskeletal stress in retinal pigment epithelium of eyes with age-related macular degeneration.Classical complement activation and acquired immune response pathways are not essential for retinal degeneration in the rd1 mouseRefMoB, a Reflectivity Feature Model-Based Automated Method for Measuring Four Outer Retinal Hyperreflective Bands in Optical Coherence Tomography.Scotopic sensitivity and color vision with a blue-light-absorbing intraocular lens.Relationship between slow visual processing and reading speed in people with macular degeneration.Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration.Comparison of Visual Function in Older Eyes in the Earliest Stages of Age-related Macular Degeneration to Those in Normal Macular HealthAge-related macular degeneration: a target for nanotechnology derived medicinesAssessment of age changes and repeatability for computer-based rod dark adaptation.Improved cell metabolism prolongs photoreceptor survival upon retinal-pigmented epithelium loss in the sodium iodate induced model of geographic atrophyEvaluating the performance of the quick CSF method in detecting contrast sensitivity function changesTherapeutic margins in a novel preclinical model of retinitis pigmentosa.Expression and distribution of peroxiredoxins in the retina and optic nerve.Mid-stage intervention achieves similar efficacy as conventional early-stage treatment using gene therapy in a pre-clinical model of retinitis pigmentosa
P2860
Q24676430-1164E13B-8677-49AF-AF66-3A9280A5D6AEQ26744106-BA483FD0-0FDF-427D-B4FE-05EE1E5AD9FAQ28385442-E8B3F970-DED9-44BF-9813-A82317E6B370Q28817772-3D2FED92-E1CA-46DC-B757-150FA14B704AQ30422343-4BD022BE-6D7C-4C41-86A8-C9DD82F4BA53Q30661642-EA121E29-DD99-4C9B-9A77-DACA40DBF1BFQ33343534-F17A11B4-AC46-4333-97EF-5382ACAB864AQ33356851-720F9664-68C9-4CE8-AD0D-254D213E03EEQ33755559-E1437C93-C16E-4884-980C-3D2E34D3AB02Q33796324-9D15D9BF-5CF4-43E3-B0ED-75E62E05BC11Q34003267-4F1AEBEE-4098-4173-A085-73751464E86CQ34010917-5F3CFC5B-5BCE-4197-AE39-9EC3AB8F11F7Q34085363-EE46FEF0-6439-4272-A89C-0354CE6A85A0Q34121624-770DCDED-9061-43C6-87B3-BBAE11449A31Q34123468-0E8B5461-5C53-4A10-8626-41DB3CC353CEQ34274994-64D83EA1-913B-47B6-9CB1-0C9A4DC43E30Q34397034-B4A1AF2F-A96D-4148-9115-F13E79F80883Q34440797-5E430012-09DB-41F8-A87B-73C95A5AE8C5Q34500095-F3506642-3F52-44A0-ABBA-69103E5468F2Q34588628-16297C2F-F8FE-4F1C-A3C2-221520DA66DAQ34645603-B1381F86-0B9E-4397-88EE-983E3E3C50E2Q34882591-6FA90CC3-4046-477B-AFDE-9D7090F92A1FQ35048449-5B7DE0D8-8E4E-4818-9DD6-A2BB6DD3D790Q35088925-0E142110-B1D2-45B9-936D-354D0E87D8D0Q35121750-800290A6-3079-4356-A571-D01A13CBD258Q35253841-EF5690A0-EBBC-4C8B-9FE0-B846D72CE195Q35574893-DC796202-AF70-4026-BAA6-FA4F7B6AAFECQ35828879-35E8F097-1888-455B-9B52-60B6918E93CAQ35831256-FAE71C8F-8EB4-4345-A052-CD37BF02EE89Q35880420-F2FC1B2A-1432-415A-84CD-B7B07E4C5B6EQ36169954-683205BB-2FCE-438C-9965-D8F30373B30FQ36311846-FA2A7EF1-253C-472A-93B4-8ADE5851D52BQ36535118-BA1AA9C7-FDFD-4853-9A22-A0A2AB3C0440Q36920435-79792CAA-702A-4D1B-8481-3B225AA6D50CQ36927563-1E883FDA-EBA2-427D-9607-FB5131BAC60CQ36962720-189B1827-B74D-4E26-AF4B-B0939F78620FQ36981882-C3905452-6EF2-4246-8665-5D80A3301E9EQ37093907-7D3EC843-12DE-4F75-8113-2F21B2F12A70Q37342352-DA799DF7-3D3F-4A94-AAB2-89F18A799CE7Q37406449-D8792D2C-ED14-470A-BCA2-8691B1C1B433
P2860
Spare the rods, save the cones in aging and age-related maculopathy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Spare the rods, save the cones in aging and age-related maculopathy.
@ast
Spare the rods, save the cones in aging and age-related maculopathy.
@en
type
label
Spare the rods, save the cones in aging and age-related maculopathy.
@ast
Spare the rods, save the cones in aging and age-related maculopathy.
@en
prefLabel
Spare the rods, save the cones in aging and age-related maculopathy.
@ast
Spare the rods, save the cones in aging and age-related maculopathy.
@en
P2093
P1476
Spare the rods, save the cones in aging and age-related maculopathy.
@en
P2093
P304
P407
P577
2000-07-01T00:00:00Z